Renalytix (RENXF) Stock Statistics & Valuation Metrics

Renalytix has a market cap or net worth of $36.31M. The enterprise value is ―.

Renalytix has 437,018,680 shares outstanding. The number of shares has decreased by -2.65% in one year.

Renalytix’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Renalytix is ―. Renalytix’s PEG ratio is 0.00.

In the last 12 months, Renalytix had revenue of 3.00M and earned -20.40M in profits. Earnings per share was -0.21.

In the last 12 months, operating cash flow was -23.02M and capital expenditures -4.00K, giving a free cash flow of -23.02M billion.

Renalytix pays an annual dividend of ―, resulting in a dividend yield of ―

Renalytix upcoming earnings date is Mar 26, 2026, TBA (Confirmed).

Renalytix as a current ratio of ―, with Debt / Equity ratio of -72.91%

In the past 12 months, Renalytix has paid -1.40M in taxes.

Renalytix EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Renalytix has $9.63M in cash and marketable securities with $8.21M in debt, giving a net cash position of $1.42M billion.

Gross margin is 12.27%, with operating margin of ―, and net profit margin of ―.

The average price target for Renalytix is ―, which is 11.43% higher than the current price. The consensus rating is ―